Molecular Genetics, Microbiology and Virology

, Volume 32, Issue 2, pp 109–115 | Cite as

Prevalence and molecular characterization of class 1 integrons among clinical isolates of Pseudomonas aeruginosa in Northwest of Iran

  • Hamid Reza Goli
  • Mohammad Reza Nahaei
  • Mohammad Ahangarzadeh Rezaee
  • Alka Hasani
  • Hossein Samadi Kafil
  • Mohammad AghazadehEmail author
  • Vajihe Sheikhalizadeh
Experimental Works



Integrons are introduced as the most common mechanism for resistance gene dissemination in Pseudomonas aeruginosa.

Aims and tasks

The purpose of the present study was to determine the diversity of the gene cassettes carried with class 1 integrons in clinical isolates of Pseudomonas aeruginosa.

Methods and results

One hundred clinical isolates of Pseudomonas aeruginosa from four hospitals in Northwest of Iran were investigated for antimicrobial susceptibility, presence of class 1 integrons and associated resistance gene cassettes. Seventy-one percent of isolates were multidrug resistant (MDR) and colistin was the most effective antibiotic in this study. Sixty-six isolates (66%) were contained class 1 integrons which all of them carried gene cassettes. There was a strong correlation between integron presence and multidrug resistance phenotype (p < 0.05). Amplification of the internal variable regions of class 1 integrons revealed 10 different arrays ranging in size from 0.6 to 3.5 kb. DNA sequencing analysis of class 1 integrons revealed the presence of several gene cassettes associated with resistance to aminoglycosides (aac and aad), β-lactams (bla OXA), chloramphenicol (cmlA and catB), hypothetical gene cassette encoding a hypothetical protein and an open reading frame with unknown function (orfD). The most prevalent gene cassette found within class 1 integrons was aadB (68.18%), followed by aacA4 (48.48%). To the best of our knowledge, some of the gene cassettes arrays such as aac(3)-Ic-aacA5-cmlA5 and aacA5-aadA1-cmlA5 were first identified in this study. Hospital ward was demonstrated as significant risk factors for the acquisition of class 1 integrons harboring isolates in this study (P < 0.05).


Most of gene cassette arrays in this study are reported for the first time in Iran. These show the role of integrons in dissemination of resistance genes among clinical isolates of P. aeruginosa.


Pseudomonas aeruginosa antimicrobial resistance class 1 integron gene cassette 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Henrichfreise, B., Wiegand, I., Pfister, W., and Wiedemann, B., Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation, Antimicrob. Agents Chemother., 2007, no. 51, pp. 4062–4070.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Morrison, A.J. and Wenzel, R.P., Epidemiology of infections due to Pseudomonas aeruginosa, Rev. Infect. Dis., 1984, no. 6, pp. 627–642.CrossRefGoogle Scholar
  3. 3.
    Livermore, D.M., Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?, Clin. Infect. Dis., 2002, no. 34, pp. 634–640.CrossRefPubMedGoogle Scholar
  4. 4.
    Carmeli, Y., Troillet, N., Eliopoulos, G.M., and Samore, M.H., Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents, Antimicrob. Agents Chemother., 1999, no. 43, pp. 1379–1382.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Stokes, H.W. and Hall, R.M., A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: Integrons, Mol. Microbiol., 1989, no. 3, pp. 1669–1683.CrossRefPubMedGoogle Scholar
  6. 6.
    Collis, C.M., Kim, M.J., Stokes, H.W., and Hall, R.M., Integron-encoded inti integrases preferentially recognize the adjacent cognate attI site in recombination with a 59-be site, Mol. Microbiol., 2002, no. 46, pp. 1415–1427.CrossRefPubMedGoogle Scholar
  7. 7.
    Carattoli, A., Importance of integrons in the diffusion of resistance, Vet. Res., 2001, no. 32, pp. 243–259.CrossRefPubMedGoogle Scholar
  8. 8.
    Xu, Z., Li, L., Shirtliff, M.E., Alam, M.J., Yamasaki, S., and Shi, L., Occurrence and characteristics of class 1 and 2 integrons in Pseudomonas aeruginosa isolates from patients in southern China, J. Clin. Microbiol., 2009, no. 47, pp. 230–234.CrossRefPubMedGoogle Scholar
  9. 9.
    Chen, J., Su, Z., Liu, Y., Wang, S., Dai, X., Li, Y., Peng, S., Shao, Q., Zhang, H., Wen, P., Yu, J., Huang, X., and Xu, H., Identification and characterization of class 1 integrons among Pseudomonas aeruginosa isolates from patients in Zhenjiang, China, Int. J. Infect. Dis., 2009, no. 13, pp. 717–721.CrossRefPubMedGoogle Scholar
  10. 10.
    Levesque, C., Piche, L., Larose, C., and Roy, P.H., PCR mapping of integrons reveals several novel combinations of resistance genes, Antimicrob. Agents Chemother., 1995, no. 39, pp. 185–191.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Mazel, D., Integrons: agents of bacterial evolution, Nat. Rev. Microbiol., 2006, no. 4, pp. 608–620.CrossRefPubMedGoogle Scholar
  12. 12.
    Cambray, G., Guerout, A.M., and Mazel, D., Integrons, Annu. Rev. Genet., 2010, no. 44, pp. 141–166.CrossRefPubMedGoogle Scholar
  13. 13.
    Shahcheraghi, F., Badmasti, F., and Feizabadi, M.M., Molecular characterization of class 1 integrons in MDR Pseudomonas aeruginosa isolated from clinical settings in Iran, Tehran, FEMS Immunol. Med. Microbiol., 2010, vol. 58, no. 3, pp. 421–425.CrossRefPubMedGoogle Scholar
  14. 14.
    Fonseca, E.L., Vieira, V.V., Cipriano, R., and Vicente, A.C., Class 1 integrons in Pseudomonas aeruginosa isolates from clinical settings in Amazon region, Brazil, FEMS Immunol. Med. Microbiol., 2005, no. 44, pp. 303–309.CrossRefPubMedGoogle Scholar
  15. 15.
    Wu, Y., Li, H., Li, J., and Huang, Z.H., Detection of Pseudomonas aeruginosa carried a new array of gene cassettes within class 1 integron isolated from a teaching hospital in Nanjing, China, J. Microbiol., 2008, no. 46, pp. 687–691.CrossRefGoogle Scholar
  16. 16.
    Naas, T., Poirel, L., Karim, A., and Nordmann, P., Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa, FEMS Microbiol. Lett., 1999, no. 176, pp. 411–419.PubMedGoogle Scholar
  17. 17.
    Naas, T., Mikami, Y., Imai, T., Poirel, L., and Nordmann, P., Characterization of In53, a class 1 plasmidand composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes, J. Bacteriol., 2001, no. 183, pp. 235–249.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Levesque, C., Brassar, S., Lapointe, J., and Roy, P.H., Diversity and relative strength of tandem promoters for the antibiotic-resistance genes of several integrons, Gene, 1994, no. 142, pp. 49–54.CrossRefPubMedGoogle Scholar
  19. 19.
    Hall, R.M. and Collis, C.M., Mobile gene cassettes and integrons: Capture and spread of genes by site-specific recombination, Mol. Microbiol., 1995, no. 15, pp. 593–600.CrossRefPubMedGoogle Scholar
  20. 20.
    Leverstein-Hall, M.A., Box, A.T., Blok, H.E., Paauw, A., Fluit, A.C., and Verhoef, J., Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting, J. Infect. Dis., 2002, no. 186, pp. 49–56.CrossRefGoogle Scholar
  21. 21.
    Forbes, B.A., Sahm, D., and Weissfeld, A., Diagnostic microbiology, St. Louis: Mosby, 2005.Google Scholar
  22. 22.
    Performance Standards for Antimicrobial Susceptibility Testing, 24th Informational Supplement, M100-S24, Wayne, PA: Clinical and Laboratory Standards Institute, 2014.Google Scholar
  23. 23.
    Yousefi, S., Nahaei, M., Farajnia, S., Ghojazadeh, M., Akhi, M., Sharifi, Y., Milani, M., and Ghotaslou, R., Class 1 integron and imipenem resistance in clinical isolates of Pseudomonas aeruginosa: Prevalence and antibiotic susceptibility, Iran. J. Microbiol., 2010, no. 2, pp. 115–121.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Cicek, A.C., Saral, A., Duzgun, A.O., Cizmeci, Z., Kayman, T., Balci, P.O., Dal, T., Firat, M., Yazici, Y., and Sancaktar, M., Screening of class 1 and class 2 integrons in clinical isolates of Pseudomonas aeruginosa collected from seven hospitals in Turkey: A multicenter study, Open J. Med. Microbiol., 2013, vol. 3, Art. ID 41014.Google Scholar
  25. 25.
    Nemec, A., Krizova, L., Maixnerova, M., and Musilek, M., Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic, Res. Microbiol., 2010, no. 161, pp. 234–242.CrossRefPubMedGoogle Scholar
  26. 26.
    Gu, B., Tong, M., Zhao, W., Liu, G., Ning, M., Pan, S., and Zhao, W., Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China, J. Clin. Microbiol., 2007, no. 45, pp. 241–243.CrossRefGoogle Scholar
  27. 27.
    Poonsuk, K., Tribuddharat, C., and Chuanchuen, R., Class 1 integrons in Pseudomonas aeruginosa and Acinetobacter baumannii isolated from clinical isolates, Southeast Asian J. Trop. Med. Public Health, 2012, no. 43, pp. 376–384.PubMedGoogle Scholar
  28. 28.
    Kiddee, A., Henghiranyawong, K., Yimsabai, J., Tiloklurs, M., and Niumsup, P.R., Nosocomial spread of class 1 integron-carrying extensively drug-resistant Pseudomonas aeruginosa isolates in a Thai hospital, Int. J. Antimicrob. Agents, 2013, no. 42, pp. 301–306.CrossRefPubMedGoogle Scholar
  29. 29.
    Azucena, E. and Mobashery, S., Aminoglycosidemodifying enzymes: Mechanisms of catalytic processes and inhibition, Drug Resist. Updates, 2001, no. 4, pp. 106–117.CrossRefGoogle Scholar
  30. 30.
    Riccio, M.L., Docquier, J.D., Dell’Amico, E., Luzzaro, F., Amicosante, G., and Rossolini, G.M., Novel 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ic, from a Pseudomonas aeruginosa integron, Antimicrob. Agents Chemother., 2003, no. 47, pp. 1746–1748.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Allerton Press, Inc. 2017

Authors and Affiliations

  • Hamid Reza Goli
    • 1
    • 3
    • 4
  • Mohammad Reza Nahaei
    • 1
    • 3
  • Mohammad Ahangarzadeh Rezaee
    • 2
    • 3
  • Alka Hasani
    • 2
    • 3
  • Hossein Samadi Kafil
    • 1
    • 3
  • Mohammad Aghazadeh
    • 1
    • 3
    Email author
  • Vajihe Sheikhalizadeh
    • 3
  1. 1.Drug Applied Research Center, Faculty of MedicineTabriz University of Medical SciencesTabrizIran
  2. 2.Infectious Diseases and Tropical Medicine Research Center, Faculty of MedicineTabriz University of Medical SciencesTabrizIran
  3. 3.Department of Medical Microbiology and Virology, Faculty of MedicineMazandaran University of Medical SciencesSariIran
  4. 4.Student Research CommitteeTabriz University of Medical SciencesTabrizIran

Personalised recommendations